GDNF and alcohol use disorder
- PMID: 29726054
- PMCID: PMC6215739
- DOI: 10.1111/adb.12628
GDNF and alcohol use disorder
Abstract
Glial cell line-derived neurotrophic factor (GDNF) has been extensively studied for its role in the development and maintenance of the midbrain dopaminergic system, although evidence suggests that GDNF also plays a role in drug and alcohol addiction. This review focuses on the unique actions of GDNF in the mechanisms that prevent the transition from recreational alcohol use to abuse. Specifically, we describe studies in rodents suggesting that alcohol acutely increases GDNF expression in the ventral tegmental area, which enables the activation of the mitogen-activated protein kinase signaling pathway and the gating of alcohol intake. We further provide evidence to suggest that GDNF acts in the ventral tegmental area via both nongenomic and genomic mechanisms to suppress alcohol consumption. In addition, we describe findings indicating that when this endogenous protective pathway becomes dysregulated, alcohol intake levels escalate. Finally, we describe the potential use of GDNF inducers as a novel therapeutic approach to treat alcohol use disorder.
Keywords: GDNF; addiction; alcohol; ethanol; mesolimbic system; nucleus accumbens; ventral tegmental area.
© 2018 Society for the Study of Addiction.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Adams JP, Anderson AE, Varga AW, Dineley KT, Cook RG, Pfaffinger PJ, Sweatt JD. The A-type potassium channel Kv4.2 is a substrate for the mitogen-activated protein kinase ERK. J Neurochem. 2000;75:2277–2287. - PubMed
 
- 
    - Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nature reviews Neuroscience. 2002;3:383–394. - PubMed
 
- 
    - Airavaara M, Planken A, Gaddnas H, Piepponen TP, Saarma M, Ahtee L. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. The European journal of neuroscience. 2004;20:2336–2344. - PubMed
 
Publication types
MeSH terms
Substances
Grants and funding
- R01 AA014366/AA/NIAAA NIH HHS/United States
- 1916-13/ISF/International
- R01 AA016848/AA/NIAAA NIH HHS/United States
- NARSAD 19114/Brain and Behavior Research Foundation/International
- I-2348-105.4/2014/GIF/International
- K99 AA021802/AA/NIAAA NIH HHS/United States
- Israel Antidrug Authority/International
- 968-13/ISF/International
- K99/R00 AA021802/AA/NIAAA NIH HHS/United States
- 1916-13 968-13/ISF/International
- R00 AA021802/AA/NIAAA NIH HHS/United States
- National Institute for Psychobiology in Israel/International
- R37 AA016848/AA/NIAAA NIH HHS/United States
- P50 AA017072/AA/NIAAA NIH HHS/United States
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        